This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Evaluation of Abuse Potential of Sativex
and you are
between 19 and 45
years old
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

This crossover study with six treatment sessions is to evaluate the abuse potential of three doses of Sativex as compared to Marinol and placebo, in subjects with a history of recreational marijuana use.

Provided treatments

  • Drug: Sativex
  • Drug: Sativex
  • Drug: Sativex
  • Drug: Placebo
  • Drug: Marinol
  • Drug: Marinol

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01323569. The sponsor of the trial is GW Pharmaceuticals Ltd. and it is looking for 58 volunteers for the current phase.
Official trial title:
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Abuse Potential of Sativex in Subjects With a History of Recreational Marijuana Use